Concepts (212)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Autoantibodies | 24 | 2025 | 117 | 8.020 |
Why?
|
| Antigens, Neoplasm | 19 | 2025 | 90 | 6.920 |
Why?
|
| Carcinoma, Hepatocellular | 12 | 2023 | 163 | 4.420 |
Why?
|
| Liver Neoplasms | 11 | 2023 | 224 | 3.990 |
Why?
|
| Autoantigens | 7 | 2016 | 87 | 2.310 |
Why?
|
| Antibodies, Neoplasm | 7 | 2022 | 20 | 2.150 |
Why?
|
| Autoimmunity | 4 | 2015 | 58 | 1.420 |
Why?
|
| Nuclear Proteins | 4 | 2025 | 333 | 1.410 |
Why?
|
| Membrane Proteins | 4 | 2015 | 561 | 1.350 |
Why?
|
| Neoplasms | 8 | 2018 | 1377 | 1.320 |
Why?
|
| Prostatic Neoplasms | 5 | 2025 | 1092 | 1.270 |
Why?
|
| RNA-Binding Proteins | 3 | 2016 | 161 | 1.230 |
Why?
|
| Lung Neoplasms | 4 | 2016 | 495 | 1.230 |
Why?
|
| Esophageal Neoplasms | 2 | 2023 | 140 | 1.070 |
Why?
|
| Immunologic Tests | 6 | 2017 | 11 | 1.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 12 | 2016 | 458 | 1.010 |
Why?
|
| Liver Cirrhosis | 6 | 2023 | 67 | 0.930 |
Why?
|
| Cell Proliferation | 7 | 2023 | 1455 | 0.910 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2015 | 39 | 0.860 |
Why?
|
| Case-Control Studies | 10 | 2016 | 1285 | 0.820 |
Why?
|
| Proteomics | 5 | 2016 | 378 | 0.820 |
Why?
|
| Humans | 43 | 2025 | 43102 | 0.770 |
Why?
|
| Cell Line, Tumor | 13 | 2023 | 2676 | 0.750 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2014 | 133 | 0.750 |
Why?
|
| Prostatic Hyperplasia | 3 | 2016 | 32 | 0.710 |
Why?
|
| Gene Expression | 4 | 2015 | 701 | 0.630 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2018 | 968 | 0.580 |
Why?
|
| ral GTP-Binding Proteins | 2 | 2016 | 8 | 0.580 |
Why?
|
| Microarray Analysis | 3 | 2010 | 64 | 0.580 |
Why?
|
| Blotting, Western | 7 | 2016 | 883 | 0.560 |
Why?
|
| Gene Fusion | 1 | 2018 | 7 | 0.560 |
Why?
|
| Breast Neoplasms | 5 | 2016 | 1723 | 0.560 |
Why?
|
| Eukaryotic Initiation Factors | 2 | 2015 | 13 | 0.550 |
Why?
|
| Neoplasm Proteins | 3 | 2015 | 228 | 0.520 |
Why?
|
| Sensitivity and Specificity | 6 | 2016 | 611 | 0.520 |
Why?
|
| Nerve Tissue Proteins | 3 | 2015 | 386 | 0.510 |
Why?
|
| Apoptosis | 4 | 2023 | 1568 | 0.490 |
Why?
|
| Signal Transduction | 6 | 2016 | 2157 | 0.490 |
Why?
|
| Hepatitis, Chronic | 4 | 2023 | 6 | 0.480 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2015 | 84 | 0.460 |
Why?
|
| Cell Movement | 3 | 2016 | 655 | 0.460 |
Why?
|
| Tissue Array Analysis | 4 | 2016 | 80 | 0.450 |
Why?
|
| Immunohistochemistry | 5 | 2016 | 934 | 0.450 |
Why?
|
| Neovascularization, Pathologic | 1 | 2016 | 139 | 0.450 |
Why?
|
| BRCA2 Protein | 1 | 2015 | 50 | 0.450 |
Why?
|
| BRCA1 Protein | 1 | 2015 | 58 | 0.450 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2015 | 79 | 0.440 |
Why?
|
| Aged | 11 | 2025 | 8214 | 0.440 |
Why?
|
| Cell Adhesion | 1 | 2015 | 238 | 0.430 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2014 | 52 | 0.430 |
Why?
|
| Cyclin B1 | 1 | 2014 | 18 | 0.430 |
Why?
|
| Phosphopyruvate Hydratase | 2 | 2016 | 33 | 0.420 |
Why?
|
| Glutathione Transferase | 1 | 2014 | 90 | 0.420 |
Why?
|
| alpha-Fetoproteins | 2 | 2014 | 32 | 0.410 |
Why?
|
| Early Detection of Cancer | 2 | 2016 | 449 | 0.410 |
Why?
|
| Chemokines, CC | 1 | 2014 | 55 | 0.410 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2015 | 200 | 0.410 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2015 | 203 | 0.400 |
Why?
|
| Energy Metabolism | 1 | 2014 | 187 | 0.400 |
Why?
|
| Middle Aged | 11 | 2025 | 12222 | 0.390 |
Why?
|
| Proteome | 3 | 2022 | 152 | 0.380 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 186 | 0.380 |
Why?
|
| Male | 14 | 2025 | 23409 | 0.370 |
Why?
|
| Recombinant Proteins | 4 | 2016 | 518 | 0.370 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 299 | 0.370 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2015 | 220 | 0.340 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 3 | 2015 | 39 | 0.320 |
Why?
|
| Female | 16 | 2016 | 24698 | 0.320 |
Why?
|
| Gene Knockdown Techniques | 3 | 2014 | 189 | 0.310 |
Why?
|
| Ovarian Neoplasms | 1 | 2014 | 415 | 0.310 |
Why?
|
| Cerium | 3 | 2013 | 18 | 0.290 |
Why?
|
| Molecular Biology | 1 | 2009 | 47 | 0.280 |
Why?
|
| RNA, Small Interfering | 3 | 2014 | 436 | 0.270 |
Why?
|
| ROC Curve | 3 | 2016 | 159 | 0.270 |
Why?
|
| Calcium-Binding Proteins | 1 | 2007 | 81 | 0.250 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2006 | 32 | 0.250 |
Why?
|
| Edwardsiella tarda | 2 | 2015 | 2 | 0.240 |
Why?
|
| Fish Diseases | 2 | 2015 | 8 | 0.230 |
Why?
|
| Enterobacteriaceae Infections | 2 | 2015 | 12 | 0.230 |
Why?
|
| DNA-Binding Proteins | 2 | 2016 | 561 | 0.230 |
Why?
|
| Neoplasm Staging | 2 | 2016 | 374 | 0.230 |
Why?
|
| Genes, myc | 1 | 2005 | 31 | 0.220 |
Why?
|
| Colonic Neoplasms | 1 | 2007 | 223 | 0.220 |
Why?
|
| Tumor Stem Cell Assay | 2 | 2014 | 32 | 0.220 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2015 | 196 | 0.220 |
Why?
|
| Calcium | 1 | 2007 | 491 | 0.210 |
Why?
|
| Nanoparticles | 3 | 2016 | 460 | 0.210 |
Why?
|
| Early Diagnosis | 2 | 2014 | 68 | 0.210 |
Why?
|
| Prostate-Specific Antigen | 2 | 2016 | 147 | 0.210 |
Why?
|
| Transfection | 2 | 2015 | 532 | 0.210 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2023 | 7 | 0.200 |
Why?
|
| Diterpenes, Kaurane | 1 | 2023 | 2 | 0.200 |
Why?
|
| Repressor Proteins | 1 | 2025 | 273 | 0.190 |
Why?
|
| Aged, 80 and over | 3 | 2016 | 2853 | 0.190 |
Why?
|
| Adult | 7 | 2016 | 13872 | 0.180 |
Why?
|
| Cytoskeletal Proteins | 1 | 2023 | 116 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2015 | 63 | 0.180 |
Why?
|
| Polymerase Chain Reaction | 2 | 2015 | 455 | 0.170 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2023 | 213 | 0.170 |
Why?
|
| Zea mays | 2 | 2012 | 76 | 0.170 |
Why?
|
| Disease Progression | 2 | 2016 | 667 | 0.170 |
Why?
|
| Up-Regulation | 2 | 2015 | 536 | 0.160 |
Why?
|
| Area Under Curve | 2 | 2016 | 95 | 0.150 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 440 | 0.150 |
Why?
|
| Prognosis | 2 | 2014 | 861 | 0.150 |
Why?
|
| Metabolome | 2 | 2015 | 51 | 0.140 |
Why?
|
| Young Adult | 3 | 2015 | 5080 | 0.140 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2018 | 27 | 0.140 |
Why?
|
| Transcription Factors | 1 | 2023 | 735 | 0.140 |
Why?
|
| Mammography | 2 | 2016 | 212 | 0.140 |
Why?
|
| DNA, Complementary | 2 | 2009 | 196 | 0.140 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2015 | 174 | 0.130 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2016 | 22 | 0.120 |
Why?
|
| Glycolysis | 1 | 2016 | 71 | 0.120 |
Why?
|
| Janus Kinase 2 | 1 | 2016 | 36 | 0.120 |
Why?
|
| Tumor Burden | 1 | 2016 | 84 | 0.120 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2015 | 4 | 0.120 |
Why?
|
| Microvessels | 1 | 2016 | 31 | 0.120 |
Why?
|
| Quercetin | 1 | 2016 | 46 | 0.120 |
Why?
|
| Antibody Formation | 2 | 2006 | 76 | 0.120 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2015 | 19 | 0.120 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2015 | 32 | 0.120 |
Why?
|
| RNA Stability | 1 | 2015 | 28 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2015 | 26 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 256 | 0.120 |
Why?
|
| Lipid Peroxidation | 2 | 2013 | 140 | 0.120 |
Why?
|
| Cichlids | 1 | 2015 | 9 | 0.120 |
Why?
|
| Immunotherapy | 1 | 2017 | 144 | 0.110 |
Why?
|
| Hep G2 Cells | 1 | 2015 | 63 | 0.110 |
Why?
|
| Seroepidemiologic Studies | 1 | 2015 | 74 | 0.110 |
Why?
|
| Prostate | 1 | 2016 | 155 | 0.110 |
Why?
|
| Hydrogen Peroxide | 2 | 2013 | 190 | 0.110 |
Why?
|
| Phenotype | 1 | 2018 | 780 | 0.110 |
Why?
|
| Myoelectric Complex, Migrating | 1 | 2014 | 1 | 0.110 |
Why?
|
| Autophagy | 1 | 2016 | 140 | 0.110 |
Why?
|
| Gastrointestinal Motility | 1 | 2014 | 20 | 0.110 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2014 | 64 | 0.110 |
Why?
|
| Immunity, Innate | 1 | 2015 | 171 | 0.110 |
Why?
|
| Immunoenzyme Techniques | 1 | 2014 | 114 | 0.110 |
Why?
|
| Bacterial Vaccines | 1 | 2015 | 129 | 0.110 |
Why?
|
| Esophagus | 1 | 2014 | 42 | 0.110 |
Why?
|
| Isoenzymes | 1 | 2014 | 168 | 0.110 |
Why?
|
| Zebrafish | 1 | 2015 | 146 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 734 | 0.100 |
Why?
|
| Immunity, Humoral | 1 | 2014 | 29 | 0.100 |
Why?
|
| Breast | 1 | 2015 | 139 | 0.100 |
Why?
|
| Paclitaxel | 1 | 2014 | 64 | 0.100 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 238 | 0.100 |
Why?
|
| Glucose | 1 | 2015 | 244 | 0.100 |
Why?
|
| Animals | 6 | 2018 | 16992 | 0.100 |
Why?
|
| Immune Sera | 1 | 2013 | 56 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2014 | 411 | 0.100 |
Why?
|
| Heat-Shock Proteins | 1 | 2012 | 57 | 0.090 |
Why?
|
| Alginates | 1 | 2012 | 20 | 0.090 |
Why?
|
| Protein Binding | 1 | 2015 | 1082 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 704 | 0.090 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 592 | 0.090 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 532 | 0.090 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 1067 | 0.090 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2016 | 367 | 0.090 |
Why?
|
| Liver | 1 | 2014 | 511 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2012 | 172 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2015 | 1271 | 0.080 |
Why?
|
| Time Factors | 1 | 2015 | 1857 | 0.080 |
Why?
|
| Soil Pollutants | 1 | 2012 | 105 | 0.080 |
Why?
|
| Liver Diseases | 1 | 2010 | 34 | 0.080 |
Why?
|
| Reference Standards | 1 | 2009 | 55 | 0.080 |
Why?
|
| Antioxidants | 1 | 2013 | 443 | 0.080 |
Why?
|
| Retrospective Studies | 1 | 2016 | 2544 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 1081 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 1019 | 0.080 |
Why?
|
| Gene Library | 1 | 2009 | 62 | 0.070 |
Why?
|
| Cloning, Molecular | 1 | 2009 | 314 | 0.070 |
Why?
|
| Metal Nanoparticles | 1 | 2012 | 230 | 0.070 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2008 | 78 | 0.070 |
Why?
|
| Cytoplasm | 1 | 2007 | 154 | 0.060 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2005 | 34 | 0.060 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2005 | 95 | 0.050 |
Why?
|
| Plant Shoots | 2 | 2013 | 25 | 0.050 |
Why?
|
| Plant Roots | 2 | 2013 | 180 | 0.040 |
Why?
|
| Adolescent | 1 | 2007 | 6081 | 0.030 |
Why?
|
| Radiographic Image Enhancement | 1 | 2015 | 7 | 0.030 |
Why?
|
| Vaccines, Attenuated | 1 | 2015 | 75 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2016 | 368 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 280 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2016 | 290 | 0.030 |
Why?
|
| Antibodies, Bacterial | 1 | 2015 | 117 | 0.030 |
Why?
|
| Galactosamine | 1 | 2014 | 4 | 0.030 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2015 | 83 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2016 | 408 | 0.030 |
Why?
|
| Digestion | 1 | 2014 | 14 | 0.030 |
Why?
|
| Duodenum | 1 | 2014 | 15 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 347 | 0.030 |
Why?
|
| Metabolomics | 1 | 2015 | 95 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 223 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2016 | 694 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 638 | 0.030 |
Why?
|
| Germination | 1 | 2013 | 11 | 0.020 |
Why?
|
| Chlorophyll | 1 | 2013 | 24 | 0.020 |
Why?
|
| Electrolytes | 1 | 2013 | 30 | 0.020 |
Why?
|
| Ascorbic Acid | 1 | 2013 | 74 | 0.020 |
Why?
|
| Fluorescence | 1 | 2013 | 118 | 0.020 |
Why?
|
| Drug Tolerance | 1 | 2012 | 26 | 0.020 |
Why?
|
| X-Ray Absorption Spectroscopy | 1 | 2012 | 7 | 0.020 |
Why?
|
| Hexuronic Acids | 1 | 2012 | 8 | 0.020 |
Why?
|
| Glucuronic Acid | 1 | 2012 | 8 | 0.020 |
Why?
|
| Materials Testing | 1 | 2012 | 101 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2015 | 863 | 0.020 |
Why?
|
| Surface Properties | 1 | 2012 | 160 | 0.020 |
Why?
|
| Soil | 1 | 2012 | 171 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2013 | 1003 | 0.020 |
Why?
|
| Rats | 1 | 2014 | 3735 | 0.020 |
Why?
|